These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

143 related items for PubMed ID: 23297119

  • 1. [Cost of illness of age-related macular degeneration. Systematic review on the development of a costs diary].
    Gibbert J, Müller D, Fauser S, Stock S.
    Ophthalmologe; 2013 Jun; 110(6):528-36. PubMed ID: 23297119
    [Abstract] [Full Text] [Related]

  • 2. Economic burden of bilateral neovascular age-related macular degeneration: multi-country observational study.
    Cruess AF, Zlateva G, Xu X, Soubrane G, Pauleikhoff D, Lotery A, Mones J, Buggage R, Schaefer C, Knight T, Goss TF.
    Pharmacoeconomics; 2008 Jun; 26(1):57-73. PubMed ID: 18088159
    [Abstract] [Full Text] [Related]

  • 3. [Neovascular age-related macular degeneration in Germany. Encroachment on the quality of life and the financial implications].
    Pauleikhoff D, Scheider A, Wiedmann P, Gelisken F, Scholl HP, Roider I, Mohr A, Zlateva G, Xu X.
    Ophthalmologe; 2009 Mar; 106(3):242-51. PubMed ID: 18709375
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Incremental economic burden associated with exudative age-related macular degeneration: a population-based study.
    Kim S, Park SJ, Byun SJ, Park KH, Suh HS.
    BMC Health Serv Res; 2019 Nov 12; 19(1):828. PubMed ID: 31718629
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The depletion of susceptibles effect in the assessment of burden-of-illness: the example of age-related macular degeneration in the community-dwelling elderly population of Quebec.
    Tournier M, Moride Y, Lesk M, Ducruet T, Rochon S.
    Can J Clin Pharmacol; 2008 Nov 12; 15(1):e22-35. PubMed ID: 18579928
    [Abstract] [Full Text] [Related]

  • 11. Economic cost of age-related macular degeneration: a review of recent research.
    Ke KM, Chakravarthy U, O'Neill C.
    Drugs Aging; 2006 Nov 12; 23(3):217-25. PubMed ID: 16608377
    [Abstract] [Full Text] [Related]

  • 12. Burden of illness, visual impairment and health resource utilisation of patients with neovascular age-related macular degeneration: results from the UK cohort of a five-country cross-sectional study.
    Lotery A, Xu X, Zlatava G, Loftus J.
    Br J Ophthalmol; 2007 Oct 12; 91(10):1303-7. PubMed ID: 17504847
    [Abstract] [Full Text] [Related]

  • 13. The burden of age-related macular degeneration: results of a cohort study in two French referral centres.
    Bonastre J, Le Pen C, Soubrane G, Quentel G.
    Pharmacoeconomics; 2003 Oct 12; 21(3):181-90. PubMed ID: 12558468
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The cost-effectiveness of systematic screening for age-related macular degeneration in South Korea.
    Ra H, Song LD, Choi JA, Jee D.
    PLoS One; 2018 Oct 12; 13(10):e0206690. PubMed ID: 30379971
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Eye-related medicare costs for patients with age-related macular degeneration from 1995 to 1999.
    Coleman AL, Yu F.
    Ophthalmology; 2008 Jan 12; 115(1):18-25. PubMed ID: 17572499
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.